Press Release: ONCODESIGN Announces the Separation of Its Two Business Lines -- Service and Biotech...
Press Release: ONCODESIGN Announces the Separation of Its Two Business Lines -- Service and Biotech -- and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer
About this item
Full title
Press Release: ONCODESIGN Announces the Separation of Its Two Business Lines -- Service and Biotech -- and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer
Publisher
New York: Dow Jones & Company Inc
Journal title
Dow Jones Institutional News, 2022
Language
English
Formats
Publication information
Publisher
New York: Dow Jones & Company Inc
Subjects
More information
Alternative Titles
Full title
Press Release: ONCODESIGN Announces the Separation of Its Two Business Lines -- Service and Biotech -- and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_2682987398
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2682987398
How to access this item
Log in as a Library member
